Remote Evaluation of MIND Diet

Description

The goal of this clinical trial is to learn if increasing adherence to a Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet pattern improves thinking ability and memory compared to a healthy control diet in persons with Multiple Sclerosis (MS). The main question it aims to answer is: Does the MIND diet improve cognitive performance relative to a control diet in persons with MS? Participants will: Consume one meal that follows the MIND diet or a control meal every day for 3 months, complete online surveys and cognitive testing before and after, and keep a record of the food they eat during the study.

Conditions

Multiple Sclerosis, Cognitive Change, Nutrition, Healthy

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this clinical trial is to learn if increasing adherence to a Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet pattern improves thinking ability and memory compared to a healthy control diet in persons with Multiple Sclerosis (MS). The main question it aims to answer is: Does the MIND diet improve cognitive performance relative to a control diet in persons with MS? Participants will: Consume one meal that follows the MIND diet or a control meal every day for 3 months, complete online surveys and cognitive testing before and after, and keep a record of the food they eat during the study.

Remote Evaluation of MIND Diet

Remote Evaluation of MIND Diet

Condition
Multiple Sclerosis
Intervention / Treatment

-

Contacts and Locations

Urbana

University of Illinois Urbana-Champaign, Urbana, Illinois, United States, 61801

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Individuals aged 18-64 years old
  • 2. Self-reported diagnosis of Multiple sclerosis (MS)
  • 3. 20/20 or corrected vision
  • 4. No other neurodegenerative disease diagnosis
  • 5. Stable disease-modifying therapy (DMT) within 6 months
  • 6. Not Pregnant or lactating
  • 7. No food allergies or intolerances
  • 8. Able to consume study meals
  • 9. Not enrolled in another dietary, exercise, or medication study during the study
  • 10. Access to a computer/laptop with internet
  • 1. Individuals younger than 18 or older than 64 years old
  • 2. No self-reported diagnosis of Multiple sclerosis (MS)
  • 3. Not 20/20 or uncorrected vision
  • 4. Other neurodegenerative disease diagnosis
  • 5. Disease modifying therapy (DMT) less than 6 months
  • 6. Pregnant or lactating
  • 7. Food allergies or intolerances
  • 8. Not able to consume study meals
  • 9. Enrolled in another dietary, exercise, or medication study during the study
  • 10. No access to a computer/laptop with internet

Ages Eligible for Study

18 Years to 64 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Illinois at Urbana-Champaign,

Naiman Khan, PhD, PRINCIPAL_INVESTIGATOR, University of Illinois Urbana-Champaign

Study Record Dates

2026-12-31